Last reviewed · How we verify

NCT04796961: IMPACT

Promoting Evidenced-Based Tobacco Smoking Cessation Treatment in Community Mental Health Clinics

Completed NA Results posted Last updated 3 September 2025
What this trial tests

NA trial testing Implementation Intervention in Tobacco Smoking in 91 participants. Completed in 31 July 2023.

Timeline
12 March 2021
Primary endpoint
18 July 2023
31 July 2023

Quick facts

Lead sponsorJohns Hopkins University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment91
Start date12 March 2021
Primary completion18 July 2023
Estimated completion31 July 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johns Hopkins University

Who can join

18 and older, any sex, with Tobacco Smoking. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Provider (Staff) Knowledge of Smoking Cessation Treatment as Assessed by a 16-item Scale Primary · Baseline, 12 months

Knowledge of evidence-based smoking cessation treatment: 16-item scale developed by our team. Items are true/false and score reflects number answered correctly. Average score range 0-16 with a higher score signifies an increased knowledge of smoking cessation treatment.

Baseline
GroupValue95% CI
Implementation Intervention13.8± 1.4
12 months
GroupValue95% CI
Implementation Intervention14.2± 1.2
Provider Self-efficacy to Deliver Evidence-based Smoking Cessation Treatment Primary · Baseline, 12 months

Self-efficacy for a four components of the smoking cessation intervention were evaluated using an instrument adapted from Compeau and Higgins' task-focused self-efficacy scale. Responses for items are on a Likert scale of 1-10. Average score range 1-10 and higher scores signify greater self-efficacy for the smoking cessation task.

Smoking Screening - Baseline
GroupValue95% CI
Counseling Providers7.1± 2
Prescribers6.6± 2.9
Smoking Screening - 12 Months
GroupValue95% CI
Counseling Providers7.2± 2.2
Prescribers7.2± 2.6
Readiness to Quit Assessment - Baseline
GroupValue95% CI
Counseling Providers6.7± 2.1
Prescribers6.1± 3.2
Readiness to Quit Assessment - 12 Months
GroupValue95% CI
Counseling Providers7.3± 2.1
Prescribers6.6± 3.2
Smoking Cessation Counseling - Baseline
GroupValue95% CI
Counseling Providers5.5± 2.8
Smoking Cessation Counseling - 12 Months
GroupValue95% CI
Counseling Providers7.0± 2.1
Smoking Cessation Pharmacotherapy - Baseline
GroupValue95% CI
Prescribers6.2± 2.8
Smoking Cessation Pharmacotherapy - 12 Months
GroupValue95% CI
Prescribers7.0± 2.9
Number of Clients Recieved Smoking Status Assessment Secondary · Baseline through 12 months

Assessment of smoking status measured by clinic documentation during client visits with the number below indicating the number of clients who had a smoking status assessment during the 12 month study period.

GroupValue95% CI
Implementation Intervention3406
Number of Clients Willing to Quit Smoking That Received a Willingness to Quit Assessment Secondary · Baseline through 12 months

Assessment of willingness to quit measured by clinic documentation during client visits, with the number below indicating the number of clients who reported smoking during a smoking status assessment who had a willingness to quit assessment during the 12 month study period.

GroupValue95% CI
Implementation Intervention1192
Number of Clients Interested in Quitting Smoking Who Received Smoking Cessation Behavioral Counseling Secondary · Baseline through 12 months

Receipt of behavioral counseling measured by clinic documentation during client visits, with the number below indicating the number of clients interested in quitting smoking that reported smoking during a smoking status assessment who staff reported as receiving behavioral counseling during the 12 months study period. Data is reported in two groups based upon whether the client had a recorded interest in quitting smoking or not, and only includes clients who reported smoking at some point during the study period. Clients can be reported in both groups if they responded differently to this que

Client Smokers Reported Interest in Quitting
GroupValue95% CI
Implementation Intervention529
Clients Not Reported Interest In Quitting Smoking
GroupValue95% CI
Implementation Intervention759
Number of Clients Interested in Quitting Smoking That Received Smoking Cessation Pharmacotherapy Secondary · Baseline through 12 months

Measured by clinic documentation during client visits with the number below indicating the number of clients interested in quitting smoking, that reported smoking during a smoking status assessment who staff reported as receiving smoking cessation pharmacotherapy during the 12 months study period. Clients can be reported in both groups (Interested in quitting, not interested in quitting) if they responded differently to this question at two points over the course of the 12 months.

Client Smokers Reported Interest in Quitting
GroupValue95% CI
Implementation Intervention232
Client Smokers Not Reported Interest in Quitting
GroupValue95% CI
Implementation Intervention173
Acceptability of Evidence-based Practices Based on Adaptation of Acceptability of Intervention Measure Secondary · Post Training (up to 2 weeks), 12 months

An adaptation of the Acceptability of Intervention Measure was used. Each of the items will be measured on a 5-point Likert scale, where 1=completely disagree and 5=completely agree. An average score is calculated by summing responses across all four items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater acceptability.

Post Training
GroupValue95% CI
Implementation Intervention4.1± 0.5
12 Months
GroupValue95% CI
Implementation Intervention4.0± 0.7
Appropriateness of Evidence-based Practices Based on Adaptation of the Intervention Appropriateness Measure Secondary · Post Training (up to 2 weeks), 12 Months

An adaptation of the Intervention Appropriateness Measure was used. Each of the items will be measured on a 5-point Likert scale, where 1=completely disagree and 5=completely agree. An average score is calculated by summing responses across all four items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater appropriateness.

Post Training
GroupValue95% CI
Implementation Intervention4.2± 0.5
12 Months
GroupValue95% CI
Implementation Intervention4.1± 0.7
Feasibility of Evidence-based Practices Based on Adaptation of the Feasibility of Intervention Measure Secondary · Post Training (up to 2 weeks), 12 Months

An adaptation of the Feasibility of Intervention Measure was used. Each of the items will be measured on a 5-point Likert scale, where 1=completely disagree and 5=completely agree. An average score is calculated by summing responses across all four items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater feasibility.

Post Training
GroupValue95% CI
Implementation Intervention4.1± 0.5
12 Months
GroupValue95% CI
Implementation Intervention4.0± 0.7
Acceptability of Implementation Intervention Based on Adaptation of Acceptability of Intervention Measure Secondary · Post Training (up to 2 weeks), 12 Months

An adaptation of the Acceptability of Intervention Measure was used. Each of the items will be measured on a 5-point Likert scale, where 1=completely disagree and 5=completely agree. An average score is calculated by summing responses across all four items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater acceptability.

Post Training
GroupValue95% CI
Implementation Intervention4.1± 0.6
12 Months
GroupValue95% CI
Implementation Intervention3.9± 0.7
Appropriateness of Implementation Intervention Based on Adaptation of the Intervention Appropriateness Measure Secondary · Post Training (up to 2 weeks), 12 Months

An adaptation of the Intervention Appropriateness Measure was used. Each of the items will be measured on a 5-point Likert scale, where 1=completely disagree and 5=completely agree. An average score is calculated by summing responses across all four items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater appropriateness.

Post Training
GroupValue95% CI
Implementation Intervention4.1± 0.6
12 Months
GroupValue95% CI
Implementation Intervention3.9± 0.7
Feasibility of Implementation Intervention Based on Adaptation of the Feasibility of Intervention Measure Secondary · Post Training (up to 2 weeks), 12 Months

An adaptation of the Feasibility of Intervention Measure was used. Each of the items will be measured on a 5-point Likert scale, where 1=completely disagree and 5=completely agree. An average score is calculated by summing responses across all four items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater feasibility.

Post Training
GroupValue95% CI
Implementation Intervention4.0± 0.7
12 Months
GroupValue95% CI
Implementation Intervention3.9± 0.7

Sponsor's own description

This pilot study will examine whether an implementation intervention will improve delivery of evidence-based treatment for tobacco smoking cessation for patients in community mental health clinics.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Promoting Evidence-Based Tobacco Cessation Treatment in Community Mental Health Clinics: Protocol for a Prepost Intervention Study.
    Dickerson F, Goldsholl S, Yuan CT, Dalcin A, et al · · 2023 · cited 3× · PMID 37171851 · DOI 10.2196/44787

Verify or expand the search:

Other trials of Implementation Intervention

Trials testing the same drug.

Other recruiting trials for Tobacco Smoking

Currently open trials in the same condition.

Other Johns Hopkins University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04796961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing